Introduction
Gastric cancer remains one of the most common tumors worldwide, with significant mortality rates [1] .
Radical resection with free-margin gastrectomy and extended lymphadenectomy (LN) is the preferred surgical strategy in Asian centers. The extension of the lymph node resection is associated with better survival rates, and D2 LN seems to be superior to D1 [2] [3] [4] [5] . However, D2 resection can be associated with higher morbidity and/or mortality rates [6, 7] . These results, attributed to the extended lymph node resection, could be related to the surgical team's experience, as well as their learning curve and knowledge in regard to complications of treatment. It is possible, therefore, that D1 and D2 may have similar morbidity and mortality rates, and this would enhance the beneficial effects of D2 [8] [9] [10] .
The aim of this study was to analyze the impact on morbidity and mortality of D2 LN when compared with D1 LN in patients with GC submitted to total or subtotal gastrectomy at our Institution during the past 3 years.
Patients and methods

Between 2001 and 2003
, 100 consecutive patients submitted to gastrectomy for gastric adenocarcinoma were studied. There were 61 men and 39 women. The median age was 61.5 Ϯ 13.1 years, ranging from 33 to 87 years. Twenty-nine patients (29%) had an early gastric cancer, confirmed by postoperative histological examination, and 71 patients (71%) had an advanced cancer.
The indication for performing either total or subtotal gastrectomy was based on tumor location and surgical tumor-free margins. Proximal surgical margins were determined according to the Japanese Gastric Cancer 
Results.
No difference was observed regarding complications and mortality related to the extent of the gastrectomy. Although morbidity was higher in the D1 group, no significant difference was observed. Mortality was higher in the D1 group, and this was probably related to their poor surgical condition and more advanced tumors. Conclusion. According to these results, it appears that total or subtotal gastrectomy with D2 LN in gastric cancer treatment, performed according to the Japanese guidelines, can be considered a safe procedure, with acceptable morbidity and mortality, when performed by a trained surgical team.
Association (JGCA) recommendations considering the histological type (Nakamura's differentiated or undefferentiated and/or Lauren's intestinal or diffuse type). For differentiated/intestinal-type tumors, a surgical margin of at least 5 cm was observed, and the surgical margin was at least 10 cm for undefferentiated/ diffuse-type tumors. Subtotal gastrectomy was performed in 48 patients (D1 LN in 11, and D2 LN in 37). Total gastrectomy was performed in 52 patients (D1 LN in 13, and D2 LN in 39; Table 1 ).
D2 lymphadenectomy was performed according to the Japanese Research Society for the Study of Gastric Cancer (JRSGC) guidelines. D1 lymphadenectomy was performed only in patients with severe comorbidities or in patients with early gastric cancer with minimal tumors and low probability of lymph node metastasis according to the Japanese criteria. There were 76 D2 LN resections and 24 D1 LN resections. The mean number of dissected lymph nodes was 29 Ϯ 15.5 in D1 LN and 46 Ϯ 18.7 in D2 LN (Table 1) .
Roux-en-Y reconstruction was employed in 97 patients, and Billroth II (B II) in 3.
Postoperative complications were studied, considering the extent of the gastric resection and extent of the LN; with analysis of mean surgical and anesthetic times, necessity for transfusion, associated resected organs, mean number of dissected and metastatic lymph nodes, and tumor stage (TNM). The statistical analysis was performed utilizing the 2 test and Student's t-test, with 95% confidence intervals. 
Results
The results are presented in Table 1 (patient distribution according to the extent of LN), Table 2 (patient distribution according to occurrence of complications), and Table 3 (postoperative complications and mortality rates according to extent of the LN).
Of the 24 patients with D1 LN, 5 developed respiratory complications (20.8%), which were treated with antibiotics and ventilatory support, with full recovery in 3 of them and two deaths. Three patients developed anastomotic leakage. One of these patients had a duodenal stump fistula, which was treated by conservative management. One of the other two patients developed an esophagojejunal fistula, and the other patient had a gastrojejunal fistula; both died of abdominal sepsis. The overall morbidity rate was 45.8%. Fatal outcomes were observed in 5 patients (20.8%) ( Table 3) .
Of the 76 patients with D2 LN, 5 developed respiratory complications (6.5%), which were treated by anti- biotics and ventilatory support, with full recovery in 4, and one death, which was associated with abdominal sepsis due to jejunostomy leakage. Five patients (6.5%) developed anastomotic leakage (4 due to duodenal stump fistula and 1 due to esophagojejunal fistula), which was managed conservatively in 4 patients and surgically in 1 patient (duodenal stump fistula). Seven patients (9.2%) developed cavitary abscesses, mostly in the left subphrenic space. Four were treated conservatively with drainage and antibiotics, and 3 were operated, with one death. The overall morbidity rate was 27.6%. Fatal outcomes were observed in 3 patients (3.9%) ( Table 3 ). The incidence of complications was higher in the D1 LN group, but this difference was not statistically significant (P ϭ 0.09). When complications were considered individually, respiratory complications were the only ones that reached a statistically significant difference between the D1 LN and D2 LN groups (P ϭ 0.04). Although seven patients in the D2 LN group had cavitary abscesses and in the D1 LN group none, had this complication, the difference was not statistically significant (P ϭ 0.12).
Also, associated resection of other organs showed an important correlation with morbidity, independently of the extent of the LN or the gastrectomy (Table 2) .
Mortality rates were significantly higher in patients treated by D1 LN (20.8%) when compared to D2 LN (3.9%).
Discussion
Extended LN was introduced in Japan in late 1960, for the treatment of gastric cancer, and has been shown to be associated with better overall survival [11, 12] . Since that time, this procedure has been well accepted in Japan and is currently the procedure of choice for the treatment of gastric cancer in Japan.
In the Western world, an early review of 1983 patients with gastric cancer treated by extended lymphadenectomy, reported by Gilbertsen [13] , showed no beneficial effect on overall survival rates. These results led several centers in the West to abandon this procedure as the preferred treatment strategy.
Advances in intensive care, anesthesiology, and perioperative procedures have significantly reduced the morbidity and mortality rates associated with major gastric operations [5, 14, 15] . Furthermore, the excellent results obtained in Japan with extended LN for the treatment of gastric cancer [16] have led to several studies that have compared survival, and morbidity and mortality rates associated with different LN procedures.
In the Netherlands, a randomized multicenter study was performed between 1990 and 1993, including 33 hospitals and 70 surgeons [6] . Higher morbidity and mortality rates were observed in the group of patients treated by D2 LN. However, in this study, there was significant heterogeneity in surgical techniques leading to inadequate lymph node dissection, i.e., the resection of lymph nodes that were not supposed to be removed, or the missing of those that were supposed to be removed [11] . Similar results were observed in the United Kingdom in prospective and randomized trials [7] .
In both the above studies [6, 7] , the higher mortality and morbidity rates in patients treated by D2 LN were closely related to postoperative complications associated with splenectomy and distal pancreatectomy [7, 10, 17] .
In Germany, 1654 patients treated for gastric cancer were studied between 1986 and 1989. Patients treated by D2 LN had at least 25 lymph nodes removed, and those in stages II and IIIa showed better overall survival than patients treated by D1 LN. Morbidity and mortality rates were similar in both groups, independent of the LN extent [4] . In the United States, similar results were observed. Furthermore, mortality rates associated with D2 LN were as low as 1.6% [10] .
Several studies have shown that other factors can be related to an unpleasant outcome after gastrectomy for gastric cancer, and that they be even more important that the LN extent; for example, splenectomy or associated organ resection [10, [18] [19] [20] , as shown in this study. The higher morbidity and mortality rates observed in our patients treated by D1 LN could be explained by their poor medical condition, which determined the choice of a limited surgical procedure. It must also be considered that, in this group, there were only three patients with early gastric cancer; therefore, most patients in this group had advanced disease, thus enhancing the poor results.
D2 LN was performed in most of the patients, reflecting our standard procedure following the Japanese guidelines. The good postoperative outcome was probably related to a good selection of patients, and also to a standardized pattern of lymph node dissection. For differences in the morbidity and mortality rates of patients submitted to gastric resection for gastric cancer in several centers worldwide, see Table 4 .
Conclusion
In conclusion, the extended LN dissection (D2) in this study was not associated with higher morbidity and mortality rates than the D1 procedure. Therefore, the D2 procedure can be strongly considered in the surgical strategy for curative gastric cancer management.
It is noteworthy that the mortality and morbidity rates after D2 LN were lower than those reported in the Western literature [6, 7] . This could be explained by our extensive experience with the Japanese lymph node dissection method, achieved at our institution in the past 30 years. 
